obesity treatments - USA Herald

Home
Authors

America January 30, 2026

AstraZeneca China Obesity Drug Deal Worth Up to $18.5B

Biotechnology powerhouse AstraZeneca has inked a landmark licensing agreement with China’s CSPC Pharmaceutical Group Ltd., potentially worth $18.5 billion, aimed…

By Rihem Akkouche

FOLLOW US

AstraZeneca China Obesity Drug Deal Worth Up to $18.5B

Recent Posts

Kelly Warner Law Firm Blames USA Herald for Arizona Bar Investigation

Aaron Kelly Law Firm Resorts To Attacking Former Client Again On KellyWarnerLaw.com – Pattern Recognized

Arizona Bar Opens Investigation on Attorney Aaron Kelly

Scientists Identify 22 Anomalies In Interstellar Object 3I/ATLAS As It Leaves The Solar System

Iran Appears To Have Conducted Its First Major Cyberattack Against A U.S. Company, Since The War Began – New Front Opens Against American Healthcare

Hormuz Shock Hits U.S. Legal And Insurance Sectors As War Risk, Cargo Claims And Contract Fights Begin to Spread

Beyond Gas Prices The Strait of Hormuz Crisis Could Hit Fertilizer, Plastics, Aluminum And Global Supply Chains

Fani Willis Blocked From Trump Fee Fight As Georgia Judge Lets $16.8 Million Reimbursement Battle Move Forward

FOLLOW US

Recent Posts

Signup for the USA Herald exclusive Newsletter

Signup for the USA Herald
exclusive Newsletter